Discovery of Druggability-Improved Analogues by Investigation of the LL-D49194α1 Biosynthetic Pathway.
Lei DongYi ShenXian-Feng HouWen-Jun LiGong-Li TangPublished in: Organic letters (2019)
The biosynthetic gene cluster of antitumor antibiotic LL-D49194α1 (LLD) was identified and comparatively analyzed with that of trioxacarcins. The tailoring genes encoding glycosyltransferase, methyltransferase and cytochrome P450 were systematically deleted, which led to the discovery of eight compounds from the mutants. Preliminary pharmaceutical evaluation revealed two intermediates exhibiting higher cytotoxicity, stability and solubility. These results highlighted the modification pathway for LLD biosynthesis, and provided highly potent, structurally simplified "unnatural" natural products with improved druggability.